ArticleVirology journal2025
Decoding cross-talk between Mpox and HIV: insights from transcriptomics and network-based analyses.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAt present, the Monkeypox virus (MPXV) outbreak has become a significant public health concern, and its severity is increasing based on different clades globally, which, combined, are leading to severe complications. However, it was observed that MPXV infection was highly expressed in individuals with Human Immunodeficiency Virus (HIV), and the mechanism of cross-talk has not been explored.
methodsThis study employed a network-based methodology to examine the role of differentially expressed genes (DEGs) in HIV and monkeypox (Mpox) infections. The commonly shared DEGs in Mpox and HIV were examined, followed by their functional enrichment, co-expression, transcriptional factor, potential correlation with disease, and promising drug-associated network. Additionally, the docking analysis was accomplished to gain the interaction site of the compound towards these target genes.
resultsThe GEO datasets of Mpox and HIV were examined, wherein a total of 570 Mpox and 642 HIV DEGs were identified. Among them, 41 DEGs were common, and functional enrichment and pathway analysis revealed their involvement in vital biological functions and pathways. Further, the PPI and co-expression analysis of these genes was conducted, which revealed 8 key genes or hub genes, which included SOCS3, NFKBIA, IFIT1, CCNB2, PLK3, PTGS1, ZFP36L2, and RGS16. Moreover, transcription factors (TFs) and miRNAs of the hub genes were also examined, which offered new insight into potential therapeutic targets. The gene-disease network also revealed several other diseases linked to the common and hub genes. Subsequently, the docking analysis revealed that the selected compound actively bound to the target genes and could be a potential lead to combat this.
conclusionsThis study unveils the shared mechanism between HIV and Mpox based on the hub genes perspective, offering new insights into co-infection and highlighting potential possibilities for simultaneous therapeutic intervention in both diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.